Commonwealth Equity Services’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $306K | Buy |
9,695
+109
| +1% | +$3.44K | ﹤0.01% | 3560 |
|
|
2025
Q1 | $314K | Sell |
9,586
-210
| -2% | -$6.88K | ﹤0.01% | 3454 |
|
|
2024
Q4 | $354K | Sell |
9,796
-454
| -4% | -$16.4K | ﹤0.01% | 3266 |
|
|
2024
Q3 | $320K | Buy |
10,250
+55
| +0.5% | +$1.72K | ﹤0.01% | 3297 |
|
|
2024
Q2 | $273K | Buy |
10,195
+350
| +4% | +$9.37K | ﹤0.01% | 3377 |
|
|
2024
Q1 | $336K | Sell |
9,845
-185
| -2% | -$6.31K | ﹤0.01% | 3171 |
|
|
2023
Q4 | $290K | Buy |
10,030
+382
| +4% | +$11K | ﹤0.01% | 3212 |
|
|
2023
Q3 | $266K | Buy |
9,648
+197
| +2% | +$5.43K | ﹤0.01% | 3135 |
|
|
2023
Q2 | $284K | Buy |
9,451
+550
| +6% | +$16.5K | ﹤0.01% | 3101 |
|
|
2023
Q1 | $322 | Buy |
8,901
+200
| +2% | +$7 | ﹤0.01% | 2915 |
|
|
2022
Q4 | $310K | Sell |
8,701
-1,518
| -15% | -$54.1K | ﹤0.01% | 2842 |
|
|
2022
Q3 | $345K | Sell |
10,219
-385
| -4% | -$13K | ﹤0.01% | 2709 |
|
|
2022
Q2 | $306K | Buy |
10,604
+181
| +2% | +$5.22K | ﹤0.01% | 2829 |
|
|
2022
Q1 | $336K | Sell |
10,423
-286
| -3% | -$9.22K | ﹤0.01% | 2877 |
|
|
2021
Q4 | $312K | Sell |
10,709
-671
| -6% | -$19.5K | ﹤0.01% | 2942 |
|
|
2021
Q3 | $303K | Buy |
11,380
+1,440
| +14% | +$38.3K | ﹤0.01% | 2919 |
|
|
2021
Q2 | $306K | Buy |
9,940
+362
| +4% | +$11.1K | ﹤0.01% | 2879 |
|
|
2021
Q1 | $250K | Hold |
9,578
| – | – | ﹤0.01% | 2942 |
|
|
2020
Q4 | $240K | Buy |
+9,578
| New | +$240K | ﹤0.01% | 2771 |
|